Skip to main content

Breast Cancer News (Page 5)

Related terms: Breast Cancer, inflammatory, Cancer, Breast, Carcinoma, Ductal, Carcinoma, Lobular, Ductal Carcinoma in Situ (DCIS), Ductal Carcinoma in Situ, DCIS

SABCS: Adding Camrelizumab to Neoadjuvant Chemo Beneficial in TNBC

FRIDAY, Dec. 13, 2024 – The addition of camrelizumab to neoadjuvant chemotherapy improves pathological complete response for patients with early or locally advanced triple-negative breast cancer,...

SABCS: Risk-Reducing Surgery Improves Outcomes in Young Breast Cancer Patients With BRCA Mutations

MONDAY, Dec. 16, 2024 – Risk-reducing mastectomy (RRM) and salpingo-oophorectomy (RRSO) are both associated with significant improvements in outcomes among young BRCA carriers with breast cancer,...

SABCS: Chest Wall Irradiation Does Not Impact Survival in Breast Cancer

MONDAY, Dec. 16, 2024 – For patients with intermediate-risk breast cancer, chest wall irradiation (CWI) after mastectomy does not influence 10-year overall survival, according to a study presented...

Study Supports Tamoxifen for DCIS Early Breast Cancers

MONDAY, Dec. 16, 2024 – The established hormone therapy drug tamoxifen can significantly decrease the risk of cancer recurring in women with an early, low-risk form of breast cancer, a new study...

Breast, Ovary Removal Can Lengthen Lives of Women With Breast Cancer Genes

FRIDAY, Dec. 13, 2024 – It's a decision no woman wants to have to make, but new research shows that young breast cancer patients with high-risk genes may be able to prevent their cancer from...

Newer Drug Imlunestrant Could Be Advance Against Tough-to-Treat Breast Cancers

FRIDAY, Dec. 13, 2024 – An experimental hormone therapy pill has shown promise in extending the lives of women with tough-to-treat advanced breast cancer, a new clinical trial shows. The drug,...

SABCS: Omission of Axillary Staging Noninferior for Node-Negative Breast Cancer

FRIDAY, Dec. 13, 2024 – Omission of surgical axillary staging is noninferior to sentinel-lymph-node biopsy for patients with clinically node-negative, T1 or T2 invasive breast cancer, according to a...

SABCS: Active Monitoring Noninferior to Guideline Care for Ductal Carcinoma in Situ

FRIDAY, Dec. 13, 2024 – For patients with ductal carcinoma in situ (DCIS), active monitoring (AM) is noninferior to guideline-concordant care (GCC) that involves surgery with or without adjuvant...

'Watch and Wait' May Equal Active Treatment for Early DCIS Breast Cancers, Studies Find

FRIDAY, Dec. 13, 2024 – A “watch-and-wait” strategy might be the best option for some women with early-stage, low-risk breast cancer. According to two new studies presented Thursday at the San Ant...

Low-Dose Oral Minoxidil Effective for Alopecia in Breast Cancer

THURSDAY, Dec. 12, 2024 – Low-dose oral minoxidil (LDOM) is effective for alopecia in patients with breast cancer, according to a letter to the editor published online Dec. 3 in the Journal of the...

2004 to 2021 Saw Increase in Distant-Stage Breast Cancer Incidence

THURSDAY, Dec. 12, 2024 – During 2004 to 2021, there was an increase in distant-stage breast cancer incidence rates at presentation, according to a study published online Dec. 10 in Radiology. R....

SABCS: Imlunestrant Tied to Improved PFS for ER-Positive, HER2-Negative Breast Cancer With ESR1 Mutations

THURSDAY, Dec. 12, 2024 – For patients with estrogen receptor (ER)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced breast cancer, imlunestrant leads to significantly...

Women With Cancer Can Safely Use Rogaine to Curb Hair Loss

WEDNESDAY, Dec. 11, 2024 – Women worried about losing their locks during chemotherapy can safely take hair-loss drugs during breast cancer care, a new study says. Minoxidil - the active ingredient...

Women With Cancer Can Safely Use Rogaine to Curb Hair Loss

WEDNESDAY, Dec. 11, 2024 – Women worried about losing their locks during chemotherapy can safely take hair-loss drugs during breast cancer care, a new study says. Minoxidil - the active ingredient...

More Women Are Being Diagnosed With Breast Cancer at Later Stages

TUESDAY, Dec. 10, 2024 – More breast cancers are being detected later in women, giving the tumors a chance to spread and become life-threatening, a new study finds. This increase in late-stage...

Ask a question

To post your own question to our community, sign in or create an account.

Further information

Related condition support groups

Breast Cancer, Metastatic, Breast Cancer - Adjuvant, Breast Cancer - Male, Cancer

Related drug support groups

methotrexate, fluorouracil, anastrozole, letrozole, Arimidex, Herceptin, Keytruda, Femara, tamoxifen, trastuzumab, Ibrance